Trending
- Merck Partners with Isomorphic Labs to Discover AI-Designed Cancer Drugs
- Sanofi Wins FDA Approval for First Neurological Gaucher Disease Treatment
- Bionsight and Astellas Partner to Develop New Autoimmune Therapy
- Genomics and Vertex Extend Drug Discovery Partnership Worth $220 Million
- Pfizer Signs $2.6 Billion CAR-T Deal with Starna Therapeutics
- DISCO Pharmaceuticals and AbbVie Sign $2.5 Billion Cancer Drug Deal
- Recursion Secures FDA Alignment for REC-4881 Phase 3 Trial
- OBI Pharma Signs $2 Billion ADC Deal with Novartis
- Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
- GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
Top Headlines
Merck has entered into a strategic research collaboration with Isomorphic Labs to discover new cancer drug…
Sanofi Wins FDA Approval for First Neurological Gaucher Disease Treatment
Sanofi has received approval from the US Food and Drug Administration (FDA) for Infilbray (venglustat), making it…
Bionsight and Astellas Partner to Develop New Autoimmune Therapy
Bionsight has entered into a global research and development collaboration with Astellas Pharma to discover a…
Genomics and Vertex Extend Drug Discovery Partnership Worth $220 Million
Genomics Limited has extended its strategic drug discovery collaboration with Vertex Pharmaceuticals for another…
Pfizer Signs $2.6 Billion CAR-T Deal with Starna Therapeutics
Pfizer has entered into an exclusive licensing agreement with China-based biotechnology company Starna Therapeutics…
DISCO Pharmaceuticals and AbbVie Sign $2.5 Billion Cancer Drug Deal
DISCO Pharmaceuticals has entered into a strategic collaboration with AbbVie to discover and develop…
Featured Event
Clinical Trials
Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children
Skylark Bio has received a unanimous recommendation from an independent Data Safety Monitoring Board (DSMB) to advance its investigational gene…
Shanton Pharma Secures EMA and FDA Waivers for SAP-001
Shanton Pharma has received regulatory waivers from the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), removing the…
Boehringer Starts Phase III Trial of Verducatib for COPD
Boehringer Ingelheim has registered a new Phase III clinical trial to evaluate verducatib, an experimental oral medicine for people living with…
EyePoint’s DURAVYU Fails Main Endpoint in Phase 3 Wet AMD Trial
EyePoint, Inc. (NASDAQ: EYPT) has announced topline results from its LUCIA Phase 3 clinical trial evaluating DURAVYU (vorolanib intravitreal insert)…
Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease
Roche has received approval from the U.S. Food and Drug Administration (FDA) for Enspryng (satralizumab) to treat adults with thyroid eye disease…
Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
AstraZeneca and Ionis Pharmaceuticals have announced that their Phase III CARDIO-TTRansform trial evaluating Wainua (eplontersen) in patients with…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Drug Research
OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
OXB has confirmed its manufacturing and supply partnership with Aura Biosciences to support the late-stage…
Big Pharma Turns to AI to Find New Drugs
Big pharma is investing in AI drug discovery through major partnerships with biotech and technology companies,…
AstraZeneca Invests $2B in Summit Therapeutics for Cancer Research
AstraZeneca has agreed to invest $2 billion in Summit Therapeutics to support the development of ivonescimab and…
Sentynl, Mereo Partner to Advance Oral AATD Lung Disease Therapy
Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has…
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
Manufacturing
OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
OXB has confirmed its manufacturing and supply partnership with Aura Biosciences to support the late-stage…
Fresenius Partners with WuXi Biologics to Expand Biosimilar Pipeline
Fresenius SE & Co. KGaA has entered into an exclusive development agreement with WuXi Biologics to expand its…
SK pharmteco Invests $200M to Expand U.S. Drug Manufacturing
SK pharmteco has announced a five-year investment of more than $200 million to expand and upgrade its development…
Varda Raises $251M to Scale Space-Based Pharmaceutical Manufacturing
Varda Space Industries has raised $251 million in a Series D financing round to expand its work in space-based…
Genentech Plans $750 Million Device Manufacturing Facility in Oregon
Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device…
Fujifilm and Taiho Partner on Next-Generation ADC Manufacturing
FUJIFILM Corporation and Taiho Pharmaceutical have formed a strategic partnership to advance manufacturing…
Cellares and SonomaBio Partner on Automated Treg Cell Therapy Manufacturing
Cellares and Sonoma Biotherapeutics have announced a new collaboration to automate the manufacturing of…
Cellares, TScan Partner on Automated TSC-101 Manufacturing
Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical…
Diseases
FDA Accepts uniQure’s Gene Therapy Application for Huntington’s Disease
uniQure N.V. has received an important regulatory milestone in its effort to develop a gene therapy for…
Circular Genomics Partners with PharmatrophiX on Alzheimer’s Biomarkers
Circular Genomics and PharmatrophiX have announced a strategic collaboration to use blood-based circular RNA…
Estuary Biotherapeutics Launches with $103 Million for Kidney Gene Therapies
Estuary Biotherapeutics has launched with $103 million in committed financing to develop targeted gene therapies…
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…





















